← Browse by Condition
Medical Condition

ptsd post traumatic stress disorder

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for ptsd post traumatic stress disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — ptsd post traumatic stress disorder Clinical Trials

How many clinical trials are currently recruiting for ptsd post traumatic stress disorder?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for ptsd post traumatic stress disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ptsd post traumatic stress disorder?
ptsd post traumatic stress disorder research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ptsd post traumatic stress disorder clinical trial?
Eligibility criteria for ptsd post traumatic stress disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
NeuroBrave ltd. 1 trial
Herzog Hospital 1 trial
Almaviva Sante 1 trial
Cognitive FX 1 trial
Denzel Drop 1 trial

Recruiting Clinical Trials

NCT07462312
Recruiting
MentalGym™ and NeuroBrave™ Guided Wearable-Assisted Physiology Regulation Training for PTSD (PRTP)
Enrollment
80 pts
Location
Israel
Sponsor
NeuroBrave ltd.
View Trial →
NCT06394284 Phase 3
Recruiting
Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury
Enrollment
60 pts
Location
Israel
Sponsor
Herzog Hospital
View Trial →
NCT07525284
Recruiting
Reported Experience Measurement on Reducing Patient Discomfort in Intensive Care
Enrollment
1,242 pts
Location
France
Sponsor
Almaviva Sante
View Trial →
NCT07463703
Recruiting
Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder
Enrollment
15 pts
Location
United States
Sponsor
Cognitive FX
View Trial →
NCT06642636
Recruiting
ICU-VR Prior to ICU Admission
Enrollment
40 pts
Location
Netherlands
Sponsor
Denzel Drop
View Trial →

Related Conditions

moral injury (1) post intensive care syndrome pics (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology